Learn more about the data
Results
Arthrosamid® is a permanent injectable hydrogel that delivers long-lasting, proven pain relief without surgery — redefining treatment for knee OA.
![Adobe Stock 271209515](/_next/image?url=https%3A%2F%2Farthrosamid.ams3.cdn.digitaloceanspaces.com%2Fnew-uploads%2FHCP-Images%2F_1800xAUTO_crop_center-center_none%2FAdobeStock_271209515.jpeg&w=3840&q=75)
Pain Reduction
In all our studies , Arthrosamid® exceeds the MCID of 9 points 16 and improvement is maintained up to 3 years after a single injection.
Close to 80% Response rate
Patients in the under 70 years group reported close to 80% positive response rate following treatment with Arthrosamid®.
Safe & Effective
Arthrosamid® remains safe and effective for its intended use 3 years after treatment.
Reproducible pain reduction Results
In all our studies , Arthrosamid® exceeds the MCID of 9 points 16 and improvement is maintained up to 3 years after a single injection.
WOMAC pain subscale change from baseline across studies
Responder rates by age
Patients in the under 70 years group reported close to 80% positive response rate following treatment with Arthrosamid®.
Safety of intra-articular polyacrylamide hydrogel (iPAAG) for the treatment of knee osteoarthritis symptoms
16% of the participants had received arthroplasty surgery for knee OA of the treated knee.
There were no unexpected descriptions of abnormalities that could be associated with the prior treatment with iPAAG in the surgical reports.
“Of these patients, none reported dissatisfaction with the outcome of the surgery and the arthroplasties were well functioning.”
iPAAG: injectable polyacrylamide hydrogel
Indication, Patient Group and Usage
Arthrosamid® is intended to be used for symptomatic treatment of adult patients with knee osteoarthritis.
Treatment with Arthrosamid® may not be suitable for everyone. Your doctor is the best person to advise you.